On the chart you can see the default numbers in dynamics for BioMarin Pharmaceutical Inc. (BMRN). Companys revenue shows the average of 703.269 M which is 0.499 % gowth. The average gross profit for the whole period is 551.577 M which is 0.500 %. The average gross profit ratio is 0.929 %. The net income growth for the company last year performance is 0.184 % which equals 17.603 % % on average for the whole company history.,
Diving into the fiscal trajectory of BioMarin Pharmaceutical Inc., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of 0.073. In the realm of current assets, BMRN clocks in at 2956.088 in the reporting currency. A significant portion of these assets, precisely 1073.81, is held in cash and short-term investments. This segment shows a change of -0.169% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 615.383, if any, in the reporting currency. This indicates a difference of 84.337% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 593.095 in the reporting currency. This figure signifies a year_over_year change of 0.047%. Shareholder value, as depicted by the total shareholder equity, is valued at 4951.549 in the reporting currency. The year over year change in this aspect is 0.076%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 633.704, with an inventory valuation of 1107.18, and goodwill valued at 196.2, if any. The total intangible assets, if present, are valued at 294.7. Account payables and short-term debt are 315.51 and 502.66, respectively. The total debt is 1133.88, with a net debt of 378.75. Other current liabilities amount to 354.24, adding to the total liabilities of 1890.05. Lastly, the referred stock is valued at 0, if it exists.
The financial landscape of BioMarin Pharmaceutical Inc. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 0.164. The company recently extended its share capital by issuing 69.35, marking a difference of 1.613 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 68.85 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -111244000.000 in the reporting currency. This is a shift of 4.554 from the previous year. In the same period, the company recorded 104.39, -10920, and -2.29, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -85.79, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.
BioMarin Pharmaceutical Inc.'s revenue saw a change of 0.154% compared with the previous period. The gross profit of BMRN is reported to be 1842.16. The company's operating expenses are 1684.56, showing a change of 7.242% from the last year. The expenses for depreciation and amortization are 104.39, which is a 0.024% change from the last accounting period. Operating expenses are reported to be 1684.56, which shows a 7.242% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a 1.739% year-over-year growth. The operating income is 157.6, which shows a 1.739% change when compared to the previous year. The change in the net income is 0.184%. The net income for the last year was 167.65.
